Factor XIII deficiency is a rare but potentially life‐threatening bleeding disorder that disrupts the final stage of clot stabilisation. As a multifunctional transglutaminase, Factor XIII plays a ...

CSL Behring announced that Corifact (factor XIII concentrate [human] injection) has been approved for the routine prophylactic treatment of congenital factor XIII deficiency. Corifact is a ...

A new review article illuminates why physicians should keep coagulation disorders in mind when evaluating patients with heavy abnormal uterine bleeding. Physicians treating patients with heavy ...

Rare clotting factor deficiencies are a collection of bleeding disorders associated with issues with clotting factors. These conditions are inherited and target the proteins in the blood that control ...

Although less common than hemophilia or von Willebrand disease, inherited rare bleeding disorders, comprising afibrinogenemia and deficiencies in factors II, V, VII, X, XI, XIII or V plus VIII ...

CINCINNATI (AP) — Brynn Schulte nearly died twice when she was a baby, at one point needing emergency surgery for massive bleeding in her brain. No one knew what was wrong until a test that looked at ...

ZymoGenetics zgen is flying more than 15 percent higher to $15.08 after the Seattle firm said it has started a third clinical study to evaluate the safety and pharmacokinetics of recombinant human ...

The severity of factor X deficiency varies from person to person. Your body still produces 40% or more of the normal amount of factor X in mild cases. You may have no symptoms or only very minor ones.

THE primary purpose of this report is to describe the salutary effect of pregnancy on the coagulation defect due to factor X (Prower-Stuart factor) deficiency in a recently diagnosed case of this ...

FORT LEE, N.J., July 29, 2025 /PRNewswire/ -- Kedrion Biopharma is proud to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Coagulation Factor X ...